FDA.reportPublic FDA data

1.5 ML talquetamab-tgvs 2 MG/ML Injection [Talvey]

RxCUI
2644458
RxNorm name
1.5 ML talquetamab-tgvs 2 MG/ML Injection [Talvey]
Display name
1.5 ML talquetamab-tgvs 2 MG/ML Injection [Talvey]
Full name
1.5 ML talquetamab-tgvs 2 MG/ML Injection [Talvey]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761342Talveytalquetamab-tgvs351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9001355e-003d-4d4e-b4ce-337e0fd14952Talvey 3 MG in 1.5 ML Injection [PSN] · 1.5 ML talquetamab-tgvs 2 MG/ML Injection [Talvey] [SBD] · 1.5 ML Talvey 2 MG/ML Injection [SY] · Talvey 3 MG per 1.5 ML Injection [SY]45These highlights do not include all the information needed to use TALVEY safely and effectively. See full prescribing information for TALVEY. TALVEY ® (talquetamab-tgvs) injection, for subcutaneous use Initial U.S. Approval: 202320251008